Cargando…

Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital system

BACKGROUND: New-generation silicon-photomultiplier (SiPM)-based PET/CT systems exhibit an improved lesion detectability and image quality due to a higher detector sensitivity. Consequently, the acquisition time can be reduced while maintaining diagnostic quality. The aim of this study was to determi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fragoso Costa, Pedro, Jentzen, Walter, Brahmer, Alissa, Mavroeidi, Ilektra-Antonia, Zarrad, Fadi, Umutlu, Lale, Fendler, Wolfgang P., Rischpler, Christoph, Herrmann, Ken, Conti, Maurizio, Seifert, Robert, Sraieb, Miriam, Weber, Manuel, Kersting, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387080/ https://www.ncbi.nlm.nih.gov/pubmed/35978274 http://dx.doi.org/10.1186/s12885-022-09993-4

Ejemplares similares

Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124
por: Kersting, David, et al.
Publicado: (2021)

Evaluation of (18)F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph vision
por: Weber, Manuel, et al.
Publicado: (2021)

Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancer
por: Kersting, David, et al.
Publicado: (2021)

First experiences with dynamic renal [(68)Ga]Ga-DOTA PET/CT: a comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rate
por: Kersting, David, et al.
Publicado: (2022)

Just another “Clever Hans”? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancer
por: Weber, Manuel, et al.
Publicado: (2021)

Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology
por: Kersting, David, et al.
Publicado: (2022)

Evaluation of [(68)Ga]Ga-PSMA PET/CT images acquired with a reduced scan time duration in prostate cancer patients using the digital biograph vision
por: Weber, Manuel, et al.
Publicado: (2021)

Response to letter to the editor
por: Kersting, David, et al.
Publicado: (2022)

Artificial intelligence guided enhancement of digital PET: scans as fast as CT?
por: Hosch, René, et al.
Publicado: (2022)

Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from (68)Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient
por: Weber, Manuel, et al.
Publicado: (2020)

Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial
por: Seifert, Robert, et al.
Publicado: (2022)

Safety and Efficacy of (90)Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities
por: Fendler, Wolfgang P., et al.
Publicado: (2022)

Atypical bilateral ventilation/perfusion mismatches in an asymptomatic patient suffering from metastatic thyroid cancer
por: Kersting, David, et al.
Publicado: (2021)

N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [(18)F]FDG PET/CT compared to the histopathology reference standard
por: Hautzel, Hubertus, et al.
Publicado: (2021)

Equivalent tumor detection for early and late FAPI-46 PET acquisition
por: Ferdinandus, J., et al.
Publicado: (2021)

Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma
por: Ferdinandus, Justin, et al.
Publicado: (2022)

Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTC
por: Kersting, David, et al.
Publicado: (2021)

Fully Automated, High-Dose Radiosynthesis of [(18)F]PARPi
por: Pacelli, Anna, et al.
Publicado: (2022)

(18)F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitis
por: Deuschl, Cornelius, et al.
Publicado: (2020)

Evaluation of the Predictive Potential of 18F-FDG PET and DWI Data Sets for Relevant Prognostic Parameters of Primary Soft-Tissue Sarcomas
por: Chodyla, Michal, et al.
Publicado: (2021)

Optimization of Acquisition time of (68)Ga-PSMA-Ligand PET/MRI in Patients with Local and Metastatic Prostate Cancer
por: Lütje, Susanne, et al.
Publicado: (2016)

Multiparametric (18)F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Umutlu, Lale, et al.
Publicado: (2022)

(18)F-FDG PET/MR versus MR Alone in Whole-Body Primary Staging and Restaging of Patients with Rectal Cancer: What Is the Benefit of PET?
por: Li, Yan, et al.
Publicado: (2020)

Demonstration of the Early Cardiac Bioavailability of a Non-Specific Cell-Targeted Peptide Using Radionuclide-Based Imaging In Vivo
por: Settelmeier, Stephan, et al.
Publicado: (2023)

Quantitative (99m)Tc-DPD-SPECT/CT assessment of cardiac amyloidosis
por: Kessler, Lukas, et al.
Publicado: (2022)

Multiparametric Integrated (18)F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding
por: Umutlu, Lale, et al.
Publicado: (2021)

[(18)F]FDG PET/MRI in children suffering from lymphoma: does MRI contrast media make a difference?
por: Jannusch, Kai, et al.
Publicado: (2023)

Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients
por: Bruckmann, Nils Martin, et al.
Publicado: (2021)

Free-breathing 3D Stack of Stars GRE (StarVIBE) sequence for detecting pulmonary nodules in (18)F-FDG PET/MRI
por: Bruckmann, Nils Martin, et al.
Publicado: (2022)

Patient-specific optimisation of administered activity and acquisition times for (18)F-FDG PET imaging
por: Wickham, Fred, et al.
Publicado: (2017)

[(68)Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomas
por: Guberina, Nika, et al.
Publicado: (2022)

Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast (18)F-FDG PET/MRI compared to (18)F-FDG PET/CT and CT
por: Kirchner, Julian, et al.
Publicado: (2017)

Diagnostic accuracy of (18)F–FDG PET/CT and MR imaging in patients with adenoid cystic carcinoma
por: Ruhlmann, Verena, et al.
Publicado: (2017)

18 F-FDG-PET/MRI in patients with Graves’ orbitopathy.
por: Weber, Manuel, et al.
Publicado: (2021)

Accuracy of [(18)F]FDG PET/MRI for the Detection of Liver Metastases
por: Beiderwellen, Karsten, et al.
Publicado: (2015)

Correction: Pacelli et al. Fully Automated, High-Dose Radiosynthesis of [18F]PARPi. Pharmaceuticals 2022, 15, 865
por: Pacelli, Anna, et al.
Publicado: (2023)

Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study
por: Weber, Manuel, et al.
Publicado: (2022)

Conventional Imaging, MRI and (18)F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer
por: Morawitz, Janna, et al.
Publicado: (2023)

(18) F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine
por: Kirchner, Julian, et al.
Publicado: (2017)

Prospective evaluation of whole-body MRI and (18)F-FDG PET/MRI in N and M staging of primary breast cancer patients
por: Bruckmann, Nils Martin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4rqcsu81hlrbpjvcsa1fl2umdh